Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SRF
|
ENSG00000112658.6 | serum response factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SRF | hg19_v2_chr6_+_43140095_43140145 | 0.79 | 9.4e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_45826125 | 44.49 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chr15_-_35088340 | 30.34 |
ENST00000290378.4
|
ACTC1
|
actin, alpha, cardiac muscle 1 |
chr1_-_229569834 | 25.22 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
chr19_+_11650709 | 23.86 |
ENST00000586059.1
|
CNN1
|
calponin 1, basic, smooth muscle |
chr20_+_35169885 | 18.59 |
ENST00000279022.2
ENST00000346786.2 |
MYL9
|
myosin, light chain 9, regulatory |
chr14_-_94443065 | 18.21 |
ENST00000555287.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr14_-_94443105 | 17.53 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr19_-_36247910 | 15.58 |
ENST00000587965.1
ENST00000004982.3 |
HSPB6
|
heat shock protein, alpha-crystallin-related, B6 |
chr2_+_74120094 | 15.37 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
chr6_-_123958141 | 14.84 |
ENST00000334268.4
|
TRDN
|
triadin |
chr17_+_33474826 | 13.19 |
ENST00000268876.5
ENST00000433649.1 ENST00000378449.1 |
UNC45B
|
unc-45 homolog B (C. elegans) |
chr2_+_88367299 | 12.82 |
ENST00000419482.2
ENST00000444564.2 |
SMYD1
|
SET and MYND domain containing 1 |
chr10_+_88428370 | 12.67 |
ENST00000372066.3
ENST00000263066.6 ENST00000372056.4 ENST00000310944.6 ENST00000361373.4 ENST00000542786.1 |
LDB3
|
LIM domain binding 3 |
chr17_+_33474860 | 12.43 |
ENST00000394570.2
|
UNC45B
|
unc-45 homolog B (C. elegans) |
chr3_+_187930491 | 12.30 |
ENST00000443217.1
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr10_-_29923893 | 12.13 |
ENST00000355867.4
|
SVIL
|
supervillin |
chr3_-_52486841 | 12.01 |
ENST00000496590.1
|
TNNC1
|
troponin C type 1 (slow) |
chr6_-_123957942 | 11.68 |
ENST00000398178.3
|
TRDN
|
triadin |
chr6_-_123958051 | 11.60 |
ENST00000546248.1
|
TRDN
|
triadin |
chr9_-_35691017 | 11.55 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr2_+_88367368 | 11.53 |
ENST00000438570.1
|
SMYD1
|
SET and MYND domain containing 1 |
chr17_-_41132088 | 10.94 |
ENST00000591916.1
ENST00000451885.2 ENST00000454303.1 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
chr6_-_105585022 | 10.48 |
ENST00000314641.5
|
BVES
|
blood vessel epicardial substance |
chr6_-_123958111 | 10.48 |
ENST00000542443.1
|
TRDN
|
triadin |
chr14_-_23877474 | 10.11 |
ENST00000405093.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
chr1_-_208084387 | 9.79 |
ENST00000537704.1
|
CD34
|
CD34 molecule |
chr10_+_88428206 | 9.74 |
ENST00000429277.2
ENST00000458213.2 ENST00000352360.5 |
LDB3
|
LIM domain binding 3 |
chr2_-_106015491 | 9.68 |
ENST00000408995.1
ENST00000393353.3 ENST00000322142.8 |
FHL2
|
four and a half LIM domains 2 |
chr1_-_208084729 | 9.64 |
ENST00000310833.7
ENST00000356522.4 |
CD34
|
CD34 molecule |
chr17_-_42875115 | 9.56 |
ENST00000591137.1
|
CTC-296K1.4
|
CTC-296K1.4 |
chr2_-_106054952 | 9.47 |
ENST00000336660.5
ENST00000393352.3 ENST00000607522.1 |
FHL2
|
four and a half LIM domains 2 |
chr2_-_106015527 | 8.92 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
chr7_-_44180884 | 8.41 |
ENST00000458240.1
ENST00000223364.3 |
MYL7
|
myosin, light chain 7, regulatory |
chr18_-_3219847 | 8.36 |
ENST00000261606.7
|
MYOM1
|
myomesin 1 |
chr3_+_187930429 | 8.26 |
ENST00000420410.1
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr3_-_46904946 | 8.06 |
ENST00000292327.4
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
chr3_-_46904918 | 7.85 |
ENST00000395869.1
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
chr7_-_44180673 | 7.79 |
ENST00000457314.1
ENST00000447951.1 ENST00000431007.1 |
MYL7
|
myosin, light chain 7, regulatory |
chr10_+_123922941 | 7.70 |
ENST00000360561.3
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr18_-_3220106 | 7.69 |
ENST00000356443.4
ENST00000400569.3 |
MYOM1
|
myomesin 1 |
chr16_+_30383613 | 7.62 |
ENST00000568749.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr9_+_124088860 | 7.27 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr3_-_99594948 | 7.23 |
ENST00000471562.1
ENST00000495625.2 |
FILIP1L
|
filamin A interacting protein 1-like |
chr17_-_27949911 | 6.98 |
ENST00000492276.2
ENST00000345068.5 ENST00000584602.1 |
CORO6
|
coronin 6 |
chr3_-_99595037 | 6.83 |
ENST00000383694.2
|
FILIP1L
|
filamin A interacting protein 1-like |
chr2_-_128432639 | 6.67 |
ENST00000545738.2
ENST00000355119.4 ENST00000409808.2 |
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
chr1_+_16085263 | 6.66 |
ENST00000483633.2
ENST00000502739.1 ENST00000431771.2 |
FBLIM1
|
filamin binding LIM protein 1 |
chr2_-_161056802 | 6.50 |
ENST00000283249.2
ENST00000409872.1 |
ITGB6
|
integrin, beta 6 |
chr8_+_1993152 | 5.59 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
chr8_-_37189432 | 5.41 |
ENST00000518765.1
|
RP11-527N22.1
|
RP11-527N22.1 |
chr1_-_11907829 | 5.25 |
ENST00000376480.3
|
NPPA
|
natriuretic peptide A |
chr15_+_96873921 | 5.22 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr16_+_66413128 | 5.13 |
ENST00000563425.2
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr19_+_13135439 | 4.88 |
ENST00000586873.1
|
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr2_-_161056762 | 4.80 |
ENST00000428609.2
ENST00000409967.2 |
ITGB6
|
integrin, beta 6 |
chr10_+_75757863 | 4.76 |
ENST00000372755.3
ENST00000211998.4 ENST00000417648.2 |
VCL
|
vinculin |
chr5_-_33892118 | 4.63 |
ENST00000515401.1
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
chr8_+_1993173 | 4.59 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr7_-_27183263 | 4.52 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chrX_-_153602991 | 4.50 |
ENST00000369850.3
ENST00000422373.1 |
FLNA
|
filamin A, alpha |
chr10_-_90712520 | 4.50 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr19_+_13135386 | 4.44 |
ENST00000360105.4
ENST00000588228.1 ENST00000591028.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr11_+_117070037 | 4.44 |
ENST00000392951.4
ENST00000525531.1 ENST00000278968.6 |
TAGLN
|
transgelin |
chr5_+_137774706 | 4.43 |
ENST00000378339.2
ENST00000254901.5 ENST00000506158.1 |
REEP2
|
receptor accessory protein 2 |
chr5_-_33892204 | 4.36 |
ENST00000504830.1
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
chr5_-_169816638 | 4.36 |
ENST00000521859.1
ENST00000274629.4 |
KCNMB1
|
potassium large conductance calcium-activated channel, subfamily M, beta member 1 |
chr10_-_17659357 | 4.13 |
ENST00000326961.6
ENST00000361271.3 |
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr4_+_87928140 | 4.04 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr15_+_74218787 | 3.91 |
ENST00000261921.7
|
LOXL1
|
lysyl oxidase-like 1 |
chr5_-_58295712 | 3.90 |
ENST00000317118.8
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr11_+_86667117 | 3.90 |
ENST00000531827.1
|
RP11-736K20.6
|
RP11-736K20.6 |
chr11_-_47374246 | 3.87 |
ENST00000545968.1
ENST00000399249.2 ENST00000256993.4 |
MYBPC3
|
myosin binding protein C, cardiac |
chr1_+_16085244 | 3.87 |
ENST00000400773.1
|
FBLIM1
|
filamin binding LIM protein 1 |
chr8_-_97398865 | 3.83 |
ENST00000523862.1
|
KB-1448A5.1
|
KB-1448A5.1 |
chr22_+_36784632 | 3.71 |
ENST00000424761.1
|
RP4-633O19__A.1
|
RP4-633O19__A.1 |
chr5_-_176923846 | 3.71 |
ENST00000506537.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr18_+_61143994 | 3.65 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
chr7_-_559853 | 3.59 |
ENST00000405692.2
|
PDGFA
|
platelet-derived growth factor alpha polypeptide |
chr7_-_107643567 | 3.51 |
ENST00000393559.1
ENST00000439976.1 ENST00000393560.1 |
LAMB1
|
laminin, beta 1 |
chr16_-_3350614 | 3.45 |
ENST00000268674.2
|
TIGD7
|
tigger transposable element derived 7 |
chr4_+_186064395 | 3.43 |
ENST00000281456.6
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
chr5_+_66254698 | 3.43 |
ENST00000405643.1
ENST00000407621.1 ENST00000432426.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr5_-_176923803 | 3.43 |
ENST00000506161.1
|
PDLIM7
|
PDZ and LIM domain 7 (enigma) |
chr17_+_50939459 | 3.34 |
ENST00000412360.1
|
AC102948.2
|
Uncharacterized protein |
chr4_+_87928353 | 3.28 |
ENST00000511722.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr10_+_31610064 | 3.26 |
ENST00000446923.2
ENST00000559476.1 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
chr4_+_87928413 | 3.23 |
ENST00000544085.1
|
AFF1
|
AF4/FMR2 family, member 1 |
chr3_+_187930719 | 3.23 |
ENST00000312675.4
|
LPP
|
LIM domain containing preferred translocation partner in lipoma |
chr10_-_17659234 | 3.19 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr5_-_33892046 | 3.14 |
ENST00000352040.3
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
chr11_-_65667884 | 3.09 |
ENST00000448083.2
ENST00000531493.1 ENST00000532401.1 |
FOSL1
|
FOS-like antigen 1 |
chr5_+_150404904 | 3.09 |
ENST00000521632.1
|
GPX3
|
glutathione peroxidase 3 (plasma) |
chr11_-_2162468 | 3.06 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr11_-_65667997 | 3.05 |
ENST00000312562.2
ENST00000534222.1 |
FOSL1
|
FOS-like antigen 1 |
chr7_-_107643674 | 3.03 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr19_+_13134772 | 2.97 |
ENST00000587760.1
ENST00000585575.1 |
NFIX
|
nuclear factor I/X (CCAAT-binding transcription factor) |
chr5_+_96077888 | 2.94 |
ENST00000509259.1
ENST00000503828.1 |
CAST
|
calpastatin |
chr1_+_167599532 | 2.92 |
ENST00000537350.1
|
RCSD1
|
RCSD domain containing 1 |
chr22_+_45714672 | 2.86 |
ENST00000424557.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr12_+_52445191 | 2.81 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr7_+_114055052 | 2.71 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
chr20_+_4702548 | 2.69 |
ENST00000305817.2
|
PRND
|
prion protein 2 (dublet) |
chr6_+_151561085 | 2.63 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr16_-_11375179 | 2.59 |
ENST00000312511.3
|
PRM1
|
protamine 1 |
chr22_-_36850991 | 2.53 |
ENST00000442579.1
|
RP5-1119A7.14
|
RP5-1119A7.14 |
chr7_+_149416439 | 2.53 |
ENST00000497895.1
|
KRBA1
|
KRAB-A domain containing 1 |
chr1_+_167599330 | 2.52 |
ENST00000367854.3
ENST00000361496.3 |
RCSD1
|
RCSD domain containing 1 |
chr16_+_86229728 | 2.44 |
ENST00000601250.1
|
LINC01082
|
long intergenic non-protein coding RNA 1082 |
chr19_+_54372693 | 2.38 |
ENST00000391768.2
|
MYADM
|
myeloid-associated differentiation marker |
chr6_+_151561506 | 2.36 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr17_-_10560619 | 2.32 |
ENST00000583535.1
|
MYH3
|
myosin, heavy chain 3, skeletal muscle, embryonic |
chr8_-_22550815 | 2.29 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr19_+_54372639 | 2.29 |
ENST00000391769.2
|
MYADM
|
myeloid-associated differentiation marker |
chrX_-_11284095 | 2.28 |
ENST00000303025.6
ENST00000534860.1 |
ARHGAP6
|
Rho GTPase activating protein 6 |
chr11_-_2162162 | 2.26 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr22_-_36357671 | 2.26 |
ENST00000408983.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr2_+_101179152 | 2.25 |
ENST00000264254.6
|
PDCL3
|
phosducin-like 3 |
chr8_-_22550691 | 2.20 |
ENST00000519492.1
|
EGR3
|
early growth response 3 |
chr1_+_113263199 | 2.16 |
ENST00000361886.3
|
FAM19A3
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 |
chr12_+_54426637 | 2.05 |
ENST00000312492.2
|
HOXC5
|
homeobox C5 |
chr16_+_30077055 | 2.05 |
ENST00000564595.2
ENST00000569798.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr9_-_79520989 | 2.00 |
ENST00000376713.3
ENST00000376718.3 ENST00000428286.1 |
PRUNE2
|
prune homolog 2 (Drosophila) |
chr19_+_16177826 | 1.93 |
ENST00000589897.1
|
TPM4
|
tropomyosin 4 |
chr19_+_57901208 | 1.92 |
ENST00000366197.5
ENST00000596282.1 ENST00000597400.1 ENST00000598895.1 ENST00000336128.7 ENST00000596617.1 |
ZNF548
AC003002.6
|
zinc finger protein 548 Uncharacterized protein |
chr6_+_43139037 | 1.91 |
ENST00000265354.4
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor) |
chr1_-_168106536 | 1.90 |
ENST00000537209.1
ENST00000361697.2 ENST00000546300.1 ENST00000367835.1 |
GPR161
|
G protein-coupled receptor 161 |
chr2_+_87769459 | 1.89 |
ENST00000414030.1
ENST00000437561.1 |
LINC00152
|
long intergenic non-protein coding RNA 152 |
chr16_+_30077098 | 1.88 |
ENST00000395240.3
ENST00000566846.1 |
ALDOA
|
aldolase A, fructose-bisphosphate |
chr7_-_94285511 | 1.87 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
chr7_-_94285472 | 1.86 |
ENST00000437425.2
ENST00000447873.1 ENST00000415788.2 |
SGCE
|
sarcoglycan, epsilon |
chr7_-_94285402 | 1.80 |
ENST00000428696.2
ENST00000445866.2 |
SGCE
|
sarcoglycan, epsilon |
chr19_+_35861831 | 1.74 |
ENST00000454971.1
|
GPR42
|
G protein-coupled receptor 42 (gene/pseudogene) |
chr17_-_41132410 | 1.72 |
ENST00000409446.3
ENST00000453594.1 ENST00000409399.1 ENST00000421990.2 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
chr12_+_4382917 | 1.65 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr19_+_45971246 | 1.57 |
ENST00000585836.1
ENST00000417353.2 ENST00000353609.3 ENST00000591858.1 ENST00000443841.2 ENST00000590335.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr1_+_113263041 | 1.53 |
ENST00000369630.3
|
FAM19A3
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A3 |
chr1_-_89591749 | 1.43 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr1_+_223889310 | 1.36 |
ENST00000434648.1
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr5_+_40679584 | 1.29 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
chr22_+_38004723 | 1.28 |
ENST00000381756.5
|
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr3_-_123339418 | 1.27 |
ENST00000583087.1
|
MYLK
|
myosin light chain kinase |
chr15_+_83776324 | 1.24 |
ENST00000379390.6
ENST00000379386.4 ENST00000565774.1 ENST00000565982.1 |
TM6SF1
|
transmembrane 6 superfamily member 1 |
chr4_+_189321881 | 1.21 |
ENST00000512839.1
ENST00000513313.1 |
LINC01060
|
long intergenic non-protein coding RNA 1060 |
chr1_+_206858328 | 1.21 |
ENST00000367103.3
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2 |
chr22_+_45714301 | 1.17 |
ENST00000427777.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr19_+_1026298 | 1.13 |
ENST00000263097.4
|
CNN2
|
calponin 2 |
chr19_+_54372877 | 1.11 |
ENST00000414489.1
|
MYADM
|
myeloid-associated differentiation marker |
chr15_+_33603147 | 1.10 |
ENST00000415757.3
ENST00000389232.4 |
RYR3
|
ryanodine receptor 3 |
chr3_-_71294304 | 1.10 |
ENST00000498215.1
|
FOXP1
|
forkhead box P1 |
chr2_-_139259244 | 1.07 |
ENST00000414911.1
ENST00000431985.1 |
AC097721.2
|
AC097721.2 |
chr10_-_16859361 | 1.04 |
ENST00000377921.3
|
RSU1
|
Ras suppressor protein 1 |
chr9_+_92219919 | 1.00 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr7_+_107531580 | 0.99 |
ENST00000537148.1
ENST00000440410.1 ENST00000437604.2 |
DLD
|
dihydrolipoamide dehydrogenase |
chr3_-_157221380 | 0.99 |
ENST00000468233.1
|
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
chr14_+_105266933 | 0.97 |
ENST00000555360.1
|
ZBTB42
|
zinc finger and BTB domain containing 42 |
chr12_-_125398850 | 0.92 |
ENST00000535859.1
ENST00000546271.1 ENST00000540700.1 ENST00000546120.1 |
UBC
|
ubiquitin C |
chr10_-_16859442 | 0.91 |
ENST00000602389.1
ENST00000345264.5 |
RSU1
|
Ras suppressor protein 1 |
chr3_-_9834463 | 0.87 |
ENST00000439043.1
|
TADA3
|
transcriptional adaptor 3 |
chr3_-_157221357 | 0.86 |
ENST00000494677.1
|
VEPH1
|
ventricular zone expressed PH domain-containing 1 |
chr22_+_38004832 | 0.86 |
ENST00000405147.3
ENST00000429218.1 ENST00000325180.8 ENST00000337437.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr18_-_54318353 | 0.84 |
ENST00000590954.1
ENST00000540155.1 |
TXNL1
|
thioredoxin-like 1 |
chr2_-_96811170 | 0.84 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr13_+_27825706 | 0.80 |
ENST00000272274.4
ENST00000319826.4 ENST00000326092.4 |
RPL21
|
ribosomal protein L21 |
chr5_-_142000883 | 0.77 |
ENST00000359370.6
|
FGF1
|
fibroblast growth factor 1 (acidic) |
chr3_-_123339343 | 0.72 |
ENST00000578202.1
|
MYLK
|
myosin light chain kinase |
chr17_+_42634844 | 0.70 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
chr14_+_22992573 | 0.66 |
ENST00000390516.1
|
TRAJ21
|
T cell receptor alpha joining 21 |
chr5_-_124080203 | 0.65 |
ENST00000504926.1
|
ZNF608
|
zinc finger protein 608 |
chr19_+_1026566 | 0.65 |
ENST00000348419.3
ENST00000565096.2 ENST00000562958.2 ENST00000562075.2 ENST00000607102.1 |
CNN2
|
calponin 2 |
chr2_-_208031943 | 0.58 |
ENST00000421199.1
ENST00000457962.1 |
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr19_+_52102540 | 0.56 |
ENST00000601315.1
|
AC018755.17
|
AC018755.17 |
chr2_-_161264385 | 0.52 |
ENST00000409972.1
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr2_+_56179262 | 0.47 |
ENST00000606639.1
|
RP11-481J13.1
|
RP11-481J13.1 |
chr22_+_38004473 | 0.44 |
ENST00000414350.3
ENST00000343632.4 |
GGA1
|
golgi-associated, gamma adaptin ear containing, ARF binding protein 1 |
chr14_+_74034310 | 0.42 |
ENST00000538782.1
|
ACOT2
|
acyl-CoA thioesterase 2 |
chr13_+_42614176 | 0.38 |
ENST00000540693.1
|
DGKH
|
diacylglycerol kinase, eta |
chr12_-_50616122 | 0.38 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
chr2_+_191792376 | 0.34 |
ENST00000409428.1
ENST00000409215.1 |
GLS
|
glutaminase |
chr2_-_231989808 | 0.34 |
ENST00000258400.3
|
HTR2B
|
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
chr7_+_143078379 | 0.33 |
ENST00000449630.1
ENST00000457235.1 |
ZYX
|
zyxin |
chr1_+_11994715 | 0.32 |
ENST00000449038.1
ENST00000376369.3 ENST00000429000.2 ENST00000196061.4 |
PLOD1
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
chr19_+_16178317 | 0.31 |
ENST00000344824.6
ENST00000538887.1 |
TPM4
|
tropomyosin 4 |
chr22_+_45714361 | 0.30 |
ENST00000452238.1
|
FAM118A
|
family with sequence similarity 118, member A |
chr17_-_55911970 | 0.30 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
chr17_-_46671323 | 0.30 |
ENST00000239151.5
|
HOXB5
|
homeobox B5 |
chr2_+_26915584 | 0.28 |
ENST00000302909.3
|
KCNK3
|
potassium channel, subfamily K, member 3 |
chr17_+_73452695 | 0.28 |
ENST00000582186.1
ENST00000582455.1 ENST00000581252.1 ENST00000579208.1 |
KIAA0195
|
KIAA0195 |
chr3_-_9834375 | 0.26 |
ENST00000343450.2
ENST00000301964.2 |
TADA3
|
transcriptional adaptor 3 |
chr22_-_36784035 | 0.24 |
ENST00000216181.5
|
MYH9
|
myosin, heavy chain 9, non-muscle |
chr17_-_4890649 | 0.23 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chr22_-_50216853 | 0.23 |
ENST00000342989.5
ENST00000542442.1 |
BRD1
|
bromodomain containing 1 |
chrX_-_103499602 | 0.21 |
ENST00000372588.4
|
ESX1
|
ESX homeobox 1 |
chr4_-_10118469 | 0.21 |
ENST00000499869.2
|
WDR1
|
WD repeat domain 1 |
chr7_+_112120908 | 0.19 |
ENST00000439068.2
ENST00000312849.4 ENST00000429049.1 |
LSMEM1
|
leucine-rich single-pass membrane protein 1 |
chr12_-_50616382 | 0.16 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
chr11_-_71823715 | 0.16 |
ENST00000545944.1
ENST00000502597.2 |
ANAPC15
|
anaphase promoting complex subunit 15 |
chrX_-_101694853 | 0.15 |
ENST00000372749.1
|
NXF2B
|
nuclear RNA export factor 2B |
chr17_-_4890919 | 0.13 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chr11_+_59807748 | 0.13 |
ENST00000278855.2
ENST00000532905.1 |
PLAC1L
|
oocyte secreted protein 2 |
chr8_+_97597148 | 0.09 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.6 | 75.4 | GO:0090131 | mesenchyme migration(GO:0090131) |
12.1 | 48.6 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
6.5 | 19.4 | GO:0072011 | mesangial cell-matrix adhesion(GO:0035759) glomerular endothelium development(GO:0072011) |
4.0 | 12.1 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
3.5 | 10.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.1 | 28.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
3.0 | 12.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
2.6 | 26.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
2.6 | 44.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.5 | 4.5 | GO:0060435 | bronchiole development(GO:0060435) |
1.5 | 4.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.5 | 4.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.5 | 7.3 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
1.3 | 6.5 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 5.2 | GO:0009956 | radial pattern formation(GO:0009956) |
1.3 | 3.9 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.2 | 3.7 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
1.1 | 5.3 | GO:1902304 | positive regulation of potassium ion export(GO:1902304) |
1.0 | 3.9 | GO:0018277 | protein deamination(GO:0018277) |
1.0 | 23.9 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.9 | 11.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.9 | 10.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 6.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.7 | 4.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.7 | 5.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 2.7 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.6 | 24.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.6 | 1.9 | GO:1900222 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 3.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.6 | 3.4 | GO:0015853 | adenine transport(GO:0015853) |
0.6 | 11.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.6 | 6.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 4.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.5 | 5.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 2.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.4 | 3.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 5.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.4 | 32.0 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.4 | 15.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 3.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.4 | 5.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.3 | 2.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 3.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 16.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 35.7 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 5.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.2 | 2.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 2.8 | GO:0061469 | response to corticotropin-releasing hormone(GO:0043435) regulation of type B pancreatic cell proliferation(GO:0061469) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 3.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 18.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.2 | 2.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 24.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.2 | 12.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.2 | 1.1 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 4.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.7 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 1.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 2.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.1 | 1.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 1.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 1.6 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 3.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.1 | 1.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 7.1 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.3 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 2.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 2.3 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.0 | 0.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 1.3 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 23.8 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 5.9 | GO:0003012 | muscle system process(GO:0003012) |
0.0 | 2.6 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 6.4 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 1.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 2.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 8.0 | GO:0006260 | DNA replication(GO:0006260) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.1 | 30.5 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
5.0 | 19.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
3.8 | 11.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
3.7 | 48.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.6 | 35.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.2 | 6.5 | GO:0043257 | laminin-8 complex(GO:0043257) |
2.0 | 12.0 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
1.6 | 15.6 | GO:0032982 | myosin filament(GO:0032982) |
1.5 | 64.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.1 | 4.5 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 4.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 39.0 | GO:0036379 | myofilament(GO:0036379) |
0.7 | 12.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 23.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 32.0 | GO:0031430 | M band(GO:0031430) |
0.6 | 19.4 | GO:0046930 | pore complex(GO:0046930) |
0.6 | 16.2 | GO:0031672 | A band(GO:0031672) |
0.6 | 5.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 7.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.3 | 4.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 10.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 17.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 5.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 10.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 8.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 5.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 7.7 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.1 | GO:0000124 | SAGA complex(GO:0000124) STAGA complex(GO:0030914) |
0.0 | 4.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 5.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 2.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 6.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 33.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 2.6 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 3.8 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 3.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 3.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 11.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 2.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 44.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
3.2 | 15.9 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
1.5 | 22.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.4 | 19.4 | GO:0043199 | sulfate binding(GO:0043199) |
1.4 | 12.4 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
1.4 | 48.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.1 | 12.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.9 | 3.4 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.7 | 7.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.6 | 4.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 50.6 | GO:0017022 | myosin binding(GO:0017022) |
0.5 | 15.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 1.9 | GO:0010736 | serum response element binding(GO:0010736) |
0.4 | 2.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 1.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 24.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.4 | 10.5 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 3.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 31.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 24.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.3 | 0.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 5.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 4.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 21.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 14.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 2.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 47.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 3.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 3.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 5.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 1.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 5.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 4.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 2.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 5.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 11.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 33.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.1 | 0.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 12.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 7.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 9.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 14.7 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 3.3 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 5.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 2.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 6.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 6.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 3.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 4.4 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 5.2 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 28.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 46.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 11.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 29.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 26.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 26.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 6.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 6.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 7.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 7.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 4.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 6.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 14.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 13.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 5.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 5.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 2.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 15.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 3.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 2.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.9 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 59.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 40.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.7 | 5.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 12.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 7.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 19.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 45.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 17.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 26.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 35.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 5.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 4.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 3.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 3.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 3.6 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |